Christopher Gorman

Impact on clinical practice of a non-invasive gene expression melanoma rule-out test: 12-month follow-up of negative test results and utility data from a large US registry study.

D. Rigel, L. Ferris, S. Knezevich, 2019, Dermatology online journal.

Real-world performance and utility of a noninvasive gene expression assay to evaluate melanoma risk in pigmented lesions

L. Ferris, D. Siegel, G. Peck, 2018, Melanoma research.

Severe Prolonged Immunosuppression following Fludarabine and Rituximab Combination Therapy

J. Lester, E. Hudson, T. Maughan, 2008, Chemotherapy.